CASI News and Press, CASI Pharmaceuticals Inc. From 05/21/24

2024-05-21 09:13:41 ET More on Eli Lilly Eli Lilly: Great Time To Divest Before It Potentially Crashes Eli Lilly Remains Expensive Here - Minimal Margin Of Safety Eli Lilly: Don't Overpay For Miracle Drugs Eli Lilly’s tirzepatide cleared for diabetes t...

2024-05-15 09:00:06 ET More on CASI Pharmaceuticals CASI stock rises on positive interim data from early stage trial for its NHL treatment in China Seeking Alpha’s Quant Rating on CASI Pharmaceuticals Historical earnings data for CASI Pharmaceuticals F...

CASI Pharmaceuticals Receives FDA Clearance On The Investigational New Drug (IND) Application For CID-103 In Immune Thrombocytopenia (ITP) PR Newswire BEIJING , May 15, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a biopharmaceutical company sp...

2024-05-14 10:43:26 ET More on CASI Pharmaceuticals CASI stock rises on positive interim data from early stage trial for its NHL treatment in China Seeking Alpha’s Quant Rating on CASI Pharmaceuticals Historical earnings data for CASI Pharmaceuticals F...

CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2024 BUSINESS AND FINANCIAL RESULTS PR Newswire BEIJING , May 14, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercializin...

2024-05-02 14:31:50 ET More on Novartis, Novartis AG, etc. Novartis AG (NVS) Q1 2024 Earnings Call Transcript Novartis: Strong Start To The Year With Beat-And-Raise First Quarter Results Novartis AG 2024 Q1 - Results - Earnings Call Presentation Novartis to b...

CASI PHARMACEUTICALS REPORTS DEVELOPMENT RELATING TO ITS DISPUTES WITH JUVENTAS PR Newswire BEIJING , April 8, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing and commercia...

2024-03-28 12:53:18 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips CASI Pharmaceuticals (NASDAQ: CASI ) just reported results for the fourth quarter of 2023. CASI Pharmaceuticals reported earnings per share of -45 cents. This was below th...

2024-03-28 07:22:06 ET More on CASI Pharmaceuticals CASI stock rises on positive interim data from early stage trial for its NHL treatment in China Seeking Alpha’s Quant Rating on CASI Pharmaceuticals Historical earnings data for CASI Pharmaceuticals F...

CASI PHARMACEUTICALS ANNOUNCES FOURTH QUARTER AND FULL-YEAR 2023 BUSINESS AND FINANCIAL RESULTS PR Newswire BEIJING , March 28, 2024 /PRNewswire/ -- CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman incorporated biopharmaceutical company focused on developing a...